Diginex Acquires The Remedy Project to Bolster ESG and Supply Chain Solutions
Summary
Diginex has completed the acquisition of The Remedy Project, an ESG advisory firm, for an initial $3.79 million in shares and potential earn-outs, aiming to expand its sustainable supply chain solutions.
Key Events
-
Strategic Acquisition Closed
Diginex acquired 100% of The Remedy Project Limited, a Hong Kong-based ESG advisory company specializing in human rights due diligence and worker rights.
-
Consideration Details
The initial payment involved the issuance of 1,000,000 Diginex ordinary shares, valued at $3.79 million ($3.79 per share) at the time of the transaction.
-
Performance-Based Earn-Out
Up to an additional 1,000,000 Diginex ordinary shares are contingent on The Remedy Project meeting specific adjusted EBITDA targets over the next three years.
-
Enhanced ESG Offerings
The acquisition combines Diginex's advanced supply chain technology with The Remedy Project's expertise, creating a comprehensive ecosystem for businesses to achieve resilient, ethical operations and comply with global ESG regulations.
Analysis
Diginex's acquisition of The Remedy Project significantly enhances its ESG and supply chain technology offerings by integrating specialized human rights due diligence and remediation expertise. This strategic move positions Diginex to capitalize on growing global demand for ethical supply chain management and compliance with evolving regulations like the EU Corporate Sustainability Due Diligence Directive. The deal involves a notable share issuance, with further shares contingent on future performance, indicating a growth-oriented acquisition.
At the time of this filing, DGNX was trading at $2.72 on NASDAQ in the Technology sector, with a market capitalization of approximately $537.2M. The 52-week trading range was $0.45 to $39.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.